OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?

OptimizeRx (OPRX) delivered a standout second-quarter 2025, with revenues of $29.2 million (up 55% year over year) and earnings per share of 24 cents. Both the top and bottom lines comfortably beat their consensus mark. Strong adjusted EBITDA of$ 5.8 million and expanding gross margins underscored operational leverage, while management raised full-year revenue guidance to $104-$ 108 million. Importantly, contracted revenues climbed over 30%, signaling growing customer confidence in OPRX’s integrated solution ...